表紙
市場調査レポート

社交恐怖:世界の治験レビュー

Social Phobia Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 309952
出版日 ページ情報 英文
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
社交恐怖:世界の治験レビュー Social Phobia Global Clinical Trials Review, H2, 2014
出版日: 2014年07月31日 ページ情報: 英文
概要

当レポートでは、社交恐怖に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 社交恐怖
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要5ヶ国における治験件数
    • 中南米の主要5ヶ国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対する社交恐怖の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的な企業の治験概要
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Eli Lilly and Company
    • Pherin Pharmaceuticals, Inc.
    • Neurocrine Biosciences, Inc.
    • Mylan Inc.
    • Avera Pharmaceuticals, Inc.
    • Apsen Farmaceutica SA
  • 代表的な研究機関・病院の治験の概要
    • The University of New South Wales
    • National Institute of Mental Health
    • Umea University
    • Massachusetts General Hospital
    • Karolinska Institute
    • University of California, Los Angeles
    • University of South Florida
    • University of Pittsburgh
    • Macquarie University
    • Hamilton Health Sciences

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GlobalData

GlobalData's clinical trial report, "Social Phobia Global Clinical Trials Review, H2, 2014" provides data on the Social Phobia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Social Phobia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Social Phobia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Social Phobia
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Social Phobia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Social Phobia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Social Phobia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Pherin Pharmaceuticals, Inc.
      • Clinical Trial Overview of Pherin Pharmaceuticals, Inc.
      • Neurocrine Biosciences, Inc.
      • Clinical Trial Overview of Neurocrine Biosciences, Inc.
      • Mylan Inc.
      • Clinical Trial Overview of Mylan Inc.
      • Avera Pharmaceuticals, Inc.
      • Clinical Trial Overview of Avera Pharmaceuticals, Inc.
      • Apsen Farmaceutica SA
      • Clinical Trial Overview of Apsen Farmaceutica SA
    • Clinical Trial Overview of Top Institutes / Government
      • The University of New South Wales
      • Clinical Trial Overview of The University of New South Wales
      • National Institute of Mental Health
      • Clinical Trial Overview of National Institute of Mental Health
      • Umea University
      • Clinical Trial Overview of Umea University
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • Karolinska Institute
      • Clinical Trial Overview of Karolinska Institute
      • University of California, Los Angeles
      • Clinical Trial Overview of University of California, Los Angeles
      • University of South Florida
      • Clinical Trial Overview of University of South Florida
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Macquarie University
      • Clinical Trial Overview of Macquarie University
      • Hamilton Health Sciences
      • Clinical Trial Overview of Hamilton Health Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Social Phobia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Social Phobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Social Phobia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Social Phobia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Social Phobia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Social Phobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Social Phobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Social Phobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Social Phobia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Social Phobia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pherin Pharmaceuticals, Inc., 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Avera Pharmaceuticals, Inc., 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Apsen Farmaceutica SA, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Umea University, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Macquarie University, 2014*
  • Social Phobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014*

List of Figures

  • Social Phobia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Social Phobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Social Phobia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Social Phobia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Social Phobia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Social Phobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Social Phobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Social Phobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Social Phobia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Social Phobia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Social Phobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top